Ignite Creation Date:
2024-05-06 @ 8:06 PM
Last Modification Date:
2024-10-26 @ 3:20 PM
Study NCT ID:
NCT06250036
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-02-08
First Post:
2023-12-11
Brief Title:
Peri-operative Zimberelimab Anti-PD-1 vs Zimberelimab in Combination With Domvanalimab Anti-TIGIT in Resectable Mismatch Repair DeficientMicro-satellite Unstable Gastric and Gastro-oesophageal Junctional Adenocarcinoma ZODIAC
Sponsor:
Royal Marsden NHS Foundation Trust
Organization:
Royal Marsden NHS Foundation Trust
Organization Data
Organization:
Royal Marsden NHS Foundation Trust
Class:
OTHER
Study ID:
CCR5924
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Royal Marsden NHS Foundation Trust
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Gilead Sciences | INDUSTRY |